| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▼ | 1.49▼ | 1.48▲ | 1.44▲ | 1.76▼ |
| MA10 | 1.50▼ | 1.48▲ | 1.43▲ | 1.64▼ | 1.56▼ |
| MA20 | 1.49▼ | 1.42▲ | 1.42▲ | 1.79▼ | 1.43▲ |
| MA50 | 1.48▲ | 1.43▲ | 1.58▼ | 1.52▼ | 1.59▼ |
| MA100 | 1.43▲ | 1.61▼ | 1.77▼ | 1.42▲ | 3.42▼ |
| MA200 | 1.42▲ | 1.78▼ | 1.66▼ | 1.53▼ | 9.37▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.013▲ | 0.027▲ | -0.079▼ | 0.057▲ |
| RSI | 47.901▼ | 59.624▲ | 52.150▲ | 43.446▼ | 48.469▼ |
| STOCH | 67.063 | 76.341 | 85.954▲ | 6.742▼ | 67.966 |
| WILL %R | -71.429 | -18.367▲ | -18.367▲ | -79.101▼ | -62.717 |
| CCI | 10.945 | 66.844 | 101.989▲ | -100.317▼ | -14.022 |
|
Tuesday, April 28, 2026 01:44 PM
Biomea Fusion (NASDAQ:BMEA) executives highlighted early, exploratory clinical data for icovamenib in type 1 diabetes, presenting top-line results from the company’s COVALENT-112 proof-of-concept ...
|
|
Friday, April 24, 2026 04:58 PM
Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined ...
|
|
Tuesday, March 31, 2026 05:29 AM
Biomea Fusion (NASDAQ:BMEA) outlined several near-term clinical milestones and development priorities during a JPMorgan conference call, with executives emphasizing upcoming Phase I data for its oral ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/05/26 | 1.37 | 1.53 | 1.28 | 1.48 | 2,555,743 |
| 01/05/26 | 1.37 | 1.39 | 1.3201 | 1.37 | 1,311,727 |
| 30/04/26 | 1.47 | 1.50 | 1.35 | 1.36 | 2,015,196 |
| 29/04/26 | 1.50 | 1.54 | 1.43 | 1.45 | 1,536,950 |
| 28/04/26 | 1.72 | 1.745 | 1.53 | 1.53 | 2,243,112 |
| 27/04/26 | 1.90 | 1.925 | 1.72 | 1.73 | 2,461,247 |
| 24/04/26 | 1.89 | 1.99 | 1.85 | 1.89 | 1,249,480 |
| 23/04/26 | 1.87 | 1.925 | 1.825 | 1.87 | 1,167,701 |
| 22/04/26 | 1.94 | 1.97 | 1.785 | 1.85 | 1,624,125 |
| 21/04/26 | 2.06 | 2.06 | 1.90 | 1.91 | 1,515,839 |
|
|
||||
|
|
||||
|
|